S. OĞUZTÜZÜN Et Al. , "Prognostic Significance of Caspase 3 BCL 2 p53 and GSTP1 Expressions in Lung Adenocarcinoma," FABAD Journal of Pharmaceutical Sciences , vol.38, no.2, pp.83-89, 2016
OĞUZTÜZÜN, S. Et Al. 2016. Prognostic Significance of Caspase 3 BCL 2 p53 and GSTP1 Expressions in Lung Adenocarcinoma. FABAD Journal of Pharmaceutical Sciences , vol.38, no.2 , 83-89.
OĞUZTÜZÜN, S., ADA, A. O., KILIÇ, M., Çakır, E., & yılmaz, a., (2016). Prognostic Significance of Caspase 3 BCL 2 p53 and GSTP1 Expressions in Lung Adenocarcinoma. FABAD Journal of Pharmaceutical Sciences , vol.38, no.2, 83-89.
OĞUZTÜZÜN, SERPİL Et Al. "Prognostic Significance of Caspase 3 BCL 2 p53 and GSTP1 Expressions in Lung Adenocarcinoma," FABAD Journal of Pharmaceutical Sciences , vol.38, no.2, 83-89, 2016
OĞUZTÜZÜN, SERPİL Et Al. "Prognostic Significance of Caspase 3 BCL 2 p53 and GSTP1 Expressions in Lung Adenocarcinoma." FABAD Journal of Pharmaceutical Sciences , vol.38, no.2, pp.83-89, 2016
OĞUZTÜZÜN, S. Et Al. (2016) . "Prognostic Significance of Caspase 3 BCL 2 p53 and GSTP1 Expressions in Lung Adenocarcinoma." FABAD Journal of Pharmaceutical Sciences , vol.38, no.2, pp.83-89.
@article{article, author={SERPİL OĞUZTÜZÜN Et Al. }, title={Prognostic Significance of Caspase 3 BCL 2 p53 and GSTP1 Expressions in Lung Adenocarcinoma}, journal={FABAD Journal of Pharmaceutical Sciences}, year=2016, pages={83-89} }